Link to this page
The Drug-Drug Interactions Ontology
Last uploaded:
February 11, 2016
| Id | http://purl.obolibrary.org/obo/dinto_DB00092
http://purl.obolibrary.org/obo/dinto_DB00092
|
|---|---|
| Preferred Name | alefacept |
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| prefLabel | alefacept
|
|---|---|
| label | alefacept
|
| DBSynonym | asp0485
|
| ATCCode | L04AA15
|
| Definition | Immunosuppressive dimeric fusion protein that consists of the extracellular CD2-binding portion of the human leukocyte function antigen-3 (LFA-3) linked to the Fc (hinge, CH2 and CH3 domains) portion of human IgG1. Produced by CHO cells, mW is 91.4 kD.
|
| has pharmacological target | |
| inhibits | |
| type | |
| AHFScode | 84:92.00
|
| xref |
Wikipedia:http://en.wikipedia.org/wiki/Alefacept
PharmGKB:PA164748040
Drugs.com:http://www.drugs.com/cdi/alefacept.html
Drugs Product Database (DPD):2259052
RxList:http://www.rxlist.com/cgi/generic3/amevive.htm
|
| CASRN | 222535-22-0
|
| prefixIRI | obo2:dinto_DB00092
|
| related with |
See more
See less
|
| may interact with | |
| DBBrand | amevive
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |